Laeeq Malik - Concepedia

Author

Laeeq Malik

The University of Texas Health Science Center at San Antonio ORCID

Also Known As

L Malik, L. Malik, Laeeq Malik, Lamia Malik, R. Stuart-Harris

Publications

798

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Canberra Hospital Australian National University University of Canberra QIMR Berghofer Medical Research Institute

About

Laeeq Malik is an author at The University of Texas Health Science Center at San Antonio specializing in oncology, medicine, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	161
2	Health Sciences	3	3	49
3	Engineering	1	1	33
4	Cell Biology	1	1	22
5	Immunology	1	1	18

Laeeq Malik

Publications

480

Citations

H-Index

Page 1

	Year	Citations
LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer Tara Boulding, Robert McCuaig, A. Tan, Scientific Reports	2018	154
Targeting Nuclear LSD1 to Reprogram Cancer Cells and Reinvigorate Exhausted T Cells via a Novel LSD1-EOMES Switch Wen Juan Tu, Robert McCuaig, Abel Tan, Frontiers in Immunology	2020	56
Phase I study of intravenously administered ATI-1123, a liposomal docetaxel formulation in patients with advanced solid tumors Devalingam Mahalingam, John Nemunaitis, Laeeq Malik, Cancer Chemotherapy and Pharmacology OncologyLiposomal Docetaxel FormulationMedicineAdvanced Solid TumorsPharmacotherapy	2014	44
Predicting success in regulatory approval from Phase I results Laeeq Malik, Alex Mejia, Helen Parsons, Cancer Chemotherapy and Pharmacology ReliabilityRegulatory ApprovalEngineeringPredictive AnalyticsStatistics	2014	33
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma Devalingam Mahalingam, Laeeq Malik, Muralidhar Beeram, Cancer Chemotherapy and Pharmacology OncologyMedicineMelanomaPhase Ii StudyDual Antiangiogenic Inhibition	2014	31
Nuclear-Biased DUSP6 Expression is Associated with Cancer Spreading Including Brain Metastasis in Triple-Negative Breast Cancer Fan Wu, Robert McCuaig, Christopher R. Sutton, International Journal of Molecular Sciences Breast OncologyMedicineNuclear Dusp6Brain MetastasisPathology	2019	22
First-in-human phase 1 dose-escalation study of AV-203, a monoclonal antibody against ERBB3, in patients with metastatic or advanced solid tumors. John Sarantopoulos, Michael S. Gordon, R. Donald Harvey, Journal of Clinical Oncology ImmunologyPharmacotherapyImmunotherapeuticsImmunotherapyAdvanced Solid Tumors	2014	18
A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED) Thiru Prasanna, Laeeq Malik, Robert McCuaig, Frontiers in Oncology	2022	18
How well informed is the informed consent for cancer clinical trials? Laeeq Malik, James Kuo, Desmond Yip, Clinical Trials	2014	17
Simple and effective bacterial-based intratumoral cancer immunotherapy Christina Carroll, Erin R. Andrew, Laeeq Malik, Journal for ImmunoTherapy of Cancer	2021	17

Page 1